Laparoscopic Gastrectomy With D2 Lymphadenectomy Combined With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) or Not
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05871099 |
|
Recruitment Status :
Recruiting
First Posted : May 23, 2023
Last Update Posted : May 23, 2023
|
Sponsor:
The Affiliated Hospital of Qingdao University
Collaborators:
Shandong Cancer Hospital Affiliated to Shandong First Medical University
Chinese PLA General Hospital
Zibo Central Hospital
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Jinan Central Hospital
Qilu Hospital of Shandong University
Yantai Yuhuangding Hospital
Nanfang Hospital, Southern Medical University
Provincial Hospital Affiliated to Shandong First Medical University
The First Affiliated Hospital of Nanchang University
The Fourth Hospital of Hebei Medical University
Peking University Cancer Hospital & Institute
Peking University People's Hospital
Tianjin Cancer Hospital
First Affiliated Hospital of Xi 'an Jiaotong University
Union Hospital of Huazhong University of Science and Technology
Wuhan University
Brigham and Women's Hospital
The Second Xiangya College of Central South University
Weihai Municipal Hospital
Mountain University Cancer Hospital
Ruijin Hospital
Information provided by (Responsible Party):
The Affiliated Hospital of Qingdao University
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | November 20, 2024 |
| Estimated Study Completion Date : | November 20, 2039 |